Bluemountain Capital Managemen Sells 12,816 Shares of MedEquities Realty Trust Inc (MRT) Stock

MedEquities Realty Trust Inc (NYSE:MRT) Director Bluemountain Capital Managemen sold 12,816 shares of the company’s stock in a transaction dated Wednesday, October 10th. The shares were sold at an average price of $9.16, for a total transaction of $117,394.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Friday, October 5th, Bluemountain Capital Managemen sold 3,955 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $9.13, for a total transaction of $36,109.15.
  • On Monday, October 8th, Bluemountain Capital Managemen sold 18,052 shares of MedEquities Realty Trust stock. The shares were sold at an average price of $9.20, for a total transaction of $166,078.40.

Shares of MRT traded down $0.05 on Friday, hitting $8.78. 10,224 shares of the stock traded hands, compared to its average volume of 153,191. The company has a market capitalization of $309.70 million, a price-to-earnings ratio of 7.74 and a beta of -0.07. MedEquities Realty Trust Inc has a 1 year low of $8.82 and a 1 year high of $12.04.

MedEquities Realty Trust (NYSE:MRT) last announced its quarterly earnings data on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by ($0.20). The firm had revenue of $17.56 million for the quarter, compared to analysts’ expectations of $17.03 million. MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. As a group, equities research analysts expect that MedEquities Realty Trust Inc will post 1.08 earnings per share for the current fiscal year.

Several equities analysts recently issued reports on the stock. ValuEngine raised shares of MedEquities Realty Trust from a “sell” rating to a “hold” rating in a research note on Tuesday, July 10th. B. Riley set a $12.00 price objective on shares of MedEquities Realty Trust and gave the company a “buy” rating in a research note on Thursday, August 9th. Cantor Fitzgerald reissued a “neutral” rating and set a $10.00 price objective (down previously from $12.00) on shares of MedEquities Realty Trust in a research note on Friday, September 28th. Canaccord Genuity reduced their price objective on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, August 9th. Finally, Royal Bank of Canada set a $10.00 price objective on shares of MedEquities Realty Trust and gave the company a “hold” rating in a research note on Sunday, August 12th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company’s stock. MedEquities Realty Trust has a consensus rating of “Hold” and an average price target of $11.56.

Large investors have recently bought and sold shares of the business. Dynamic Technology Lab Private Ltd purchased a new position in MedEquities Realty Trust during the second quarter worth approximately $198,000. JPMorgan Chase & Co. raised its stake in MedEquities Realty Trust by 221.9% during the first quarter. JPMorgan Chase & Co. now owns 19,898 shares of the financial services provider’s stock worth $210,000 after purchasing an additional 13,717 shares during the period. Martingale Asset Management L P raised its stake in MedEquities Realty Trust by 2.0% during the second quarter. Martingale Asset Management L P now owns 258,242 shares of the financial services provider’s stock worth $2,846,000 after purchasing an additional 5,100 shares during the period. Putnam Investments LLC purchased a new position in MedEquities Realty Trust during the second quarter worth approximately $257,000. Finally, Dimensional Fund Advisors LP raised its stake in MedEquities Realty Trust by 143.0% during the first quarter. Dimensional Fund Advisors LP now owns 74,932 shares of the financial services provider’s stock worth $787,000 after purchasing an additional 44,097 shares during the period. 90.80% of the stock is currently owned by institutional investors.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Recommended Story: The risks of owning bonds

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply